Xin Song
- Immunology top 5%
- Rheumatology top 5%
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 7
- Cancer, Lipids, and Metabolism 5
- Hepatology top 10%
-
- Lung Cancer Research Studies 5
-
- Liver Disease Diagnosis and Treatment 7
-
- RNA modifications and cancer 7
-
- Gastric Cancer Management and Outcomes 5
- Brain Metastases and Treatment 4
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Keith B. ElkonJun ZhouDror MevorachChaohui YuChangzhou CaiXueyang ChenYishu ChenSteven Friedman
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Xin Song
49 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 94
- Immunology 585
- Rheumatology 208
- Cancer Research 190
- Hepatology 70
- Oncology 206
Countries citing papers authored by Xin Song
This map shows the geographic impact of Xin Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Song more than expected).
Fields of papers citing papers by Xin Song
This network shows the impact of papers produced by Xin Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Song. The network helps show where Xin Song may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xin Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 6 | |
| 11 | 2020 | 28 | |
| 12 | 2020 | 9 | |
| 13 | Long non-coding RNA LncHIFCAR promotes osteoarthritis development via positively regulating HIF-1α and activating the PI3K/AKT/mTOR pathway. | 2018 | 11 |
| 14 | 2015 | 0 | |
| 15 | 2015 | 1 | |
| 16 | 2011 | 7 | |
| 17 | 2010 | 21 | |
| 18 | 2010 | 16 | |
| 19 | [Radical resection of gastric or colorectal carcinoma combined with liver transplantation for gastric or colorectal carcinoma with multiple hepatic metastases]. | 2005 | 4 |
| 20 | 1998 | 467 |
About Xin Song
Xin Song is a scholar working on Cancer Research, Hepatology and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Liver Disease Diagnosis and Treatment (7 papers), RNA modifications and cancer (7 papers), Gastric Cancer Management and Outcomes (5 papers), Cancer, Lipids, and Metabolism (5 papers), Lung Cancer Research Studies (5 papers), Brain Metastases and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Immunology (585 citations), Rheumatology (208 citations) and Cancer Research (190 citations). Xin Song has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Keith B. Elkon, Jun Zhou, Dror Mevorach, Chaohui Yu, Changzhou Cai, Xueyang Chen, Yishu Chen, Steven Friedman, Elizabeth Lacy and Dalit Ashany.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.